๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation
NCT06756490Moderate or Severe Submental Fullness
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
30
Beijing, Xi'an
2024-12-26
Recruiting
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
NCT06690593Monoclonal Gammopathy of Undetermined Significance (MGUS), Intestinal Flora, Multiple Myeloma, M-Protein
Zhujiang Hospital
Observational
2,990
Guanzhou
2024-12-26
Active, closed
Spirulina Tablets Treat Liver Fibrosis/Cirrhosis
NCT06770283Liver Cirrhosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2024-12-26
Recruiting
Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
NCT06671262Breast Adenocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
74
Hangzhou
2024-12-26
Recruiting
A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
NCT07547787Locally Advanced Unresectable or Metastatic Gastric Cancer
Akeso
Observational
610
Beijing
2024-12-26
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
NCT06794008Systemic Lupus Erythematosus, Inflammatory Myopathy, Systemic Sclerosis (SSc), ANCA-associated Vasculitis
Peking University People's Hospital
Phase 2
50
Beijing
2024-12-26
Not yet open
Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer
NCT06748508Gastric (Stomach) Cancer
Fudan University
Phase 2
141
Shanghai
2024-12-25
By invitation
IIT Study on the Use of Medical Bio Glue for Repairing Meniscus Tears
NCT06878794Unilateral Meniscus Tear of the Knee Joint
First Affiliated Hospital of Ningbo University
Not applicable
60
Ningbo
2024-12-25
Not yet open
Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation
NCT06739512Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
600
Shanghai
2024-12-25
Not yet open
Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma
NCT06756841Esophageal Cancer
Energenx Medical LTD.
Not applicable
10
Shanghai
2024-12-25
By invitation
Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
NCT06753734Gestational Diabetes
Tianjin Central Hospital of Gynecology Obstetrics
Observational
600
Tianjin
2024-12-25
Active, closed
Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection
NCT06763289Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital, Sun Yat-Sen University
Observational
700
Guangzhou
2024-12-25
Recruiting
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06716658Lymphoma, T-Cell, NK-LGL Leukemia, T-LGL Leukemia, Cutaneous T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
48
Tianjin
2024-12-25
Recruiting
A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
NCT06971523Solid Tumor, Lymphoma
CytosinLab Therapeutics Co., Ltd.
Phase 1/2
224
Beijing
2024-12-25
Recruiting
Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients
NCT07050069Spinal Cord Injuries
Shengjing Hospital
Not applicable
60
Shenyang
2024-12-25
Recruiting
A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
NCT06760364Advanced Pancreatic Cancers
Tianjin Medical University Cancer Institute and Hospital
Phase 1
21
Tianjin
2024-12-25
Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors
NCT06739031NSCLC
Energenx Medical LTD.
Not applicable
126
Shanghai
2024-12-25
Recruiting
A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts.
NCT06718192Verruca Plantaris
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 1/2
70
Yiwu
2024-12-25
Recruiting
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
NCT07195500Neuroblastoma, Pheochromocytoma, Paraganglioma
Nanjing First Hospital, Nanjing Medical University
Observational
30
Nanjing
2024-12-25
Recruiting
Total Infectome Characterization of Eye Infections
NCT06775808Eye Infections, Diagnosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
200
Shanghai
2024-12-25
Recruiting
The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy
NCT06692972Lung Cancer
China-Japan Friendship Hospital
Observational
500
Beijing, Wuhan
2024-12-25
Recruiting
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
NCT06755567Head and Neck Cancer, Neoadjuvant Therapy, Immunotherapy, Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
750
Guangzhou
2024-12-25
Recruiting
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
NCT06746519Acute Myeloid Leukemia
Chen Suning
Phase 1/2
135
Suzhou
2024-12-25
Recruiting
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
NCT07444281Squamous Cell Lung Cancer
Shanghai AbelZeta Ltd.
Phase 1
24
Shanghai
2024-12-25
Not yet open
Detachable String Magnetically Controlled Capsule Endoscopy for Patients with AUGIB
NCT06725056Acute Upper Gastrointestinal Bleeding, Capsule Endoscopes
Changhai Hospital
Not applicable
120
Shanghai
2024-12-25
Recruiting
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
NCT06596018Breast Adenocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
96
Hangzhou
2024-12-25
Active, closed
A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06423885HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
64
Shanghai
2024-12-24
Active, closed
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
NCT07471880Osteonecrosis, Osteonecrosis of the Femoral Head
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Phase 2
161
Zhongshan
2024-12-24
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
NCT06556394Amyotrophic Lateral Sclerosis
Ractigen Therapeutics.
Phase 1
32
Beijing, Chengdu, Hangzhou
2024-12-24
Recruiting
Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder
NCT06457230Methamphetamine Use Disorder
Shanghai Mental Health Center
Not applicable
90
Shanghai
2024-12-24
Recruiting
An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
NCT07033156CRC (Colorectal Cancer), Adenoma Colon
Zhejiang Provincial People's Hospital
Observational
450
Hangzhou
2024-12-24
Active, closed
Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
NCT06583889Cerebral Venous Sinus Thrombosis
Beijing Tiantan Hospital
Not applicable
224
Beijing
2024-12-24
Recruiting
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
NCT06711146Systemic Lupus Erythematosus
Zhejiang University
Phase EARLY_PHASE1
36
Hangzhou
2024-12-24
Recruiting
A Strategy for Gallstone Expulsion Through Dietary Therapy
NCT06699030Gallbladder Stone
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
100
Lanzhou
2024-12-24
Not yet open
Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study
NCT06722495SBRT, Neoadjuvant Immunochemotherapy, LA HNSCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
20
Guangzhou
2024-12-24
By invitation
The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia
NCT06924515VATS, Lung Hernia
Mingjian Ge
Not applicable
104
Chongqing
2024-12-24
Recruiting
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
NCT06699212Recurrent Head and Neck Squamous Cell Carcinoma
Rakuten Medical, Inc.
Phase 3
412
2024-12-24
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
NCT06747156Autoimmune Diseases
Ruijin Hospital
Phase EARLY_PHASE1
66
Wuhan, Nanjing, Shanghai
2024-12-23
Recruiting
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638Renal Cancer, Renal Clear Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse
RenJi Hospital
Phase 2
300
Shanghai
2024-12-23
By invitation
The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery
NCT07060625Lung Cancer (Diagnosis), Hypoxemia
Shanghai Pulmonary Hospital, Shanghai, China
Observational
308
Shanghai
2024-12-23
Recruiting
Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
NCT06719791Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
15
Beijing
2024-12-23
Recruiting
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
NCT06761027Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer
Fujian Provincial Hospital
Phase 1/2
29
Fuzhou, Zhangzhou
2024-12-23
Recruiting
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NCT07026110Lung Cancer, Lung Diseases, Lung Neoplasms, Lung Cancer Metastatic
RenJi Hospital
Not applicable
100
Shanghai
2024-12-23
Recruiting
Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)
NCT07002398Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1
VeonGen Therapeutics GmbH
Phase 1/2
18
Shanghai
2024-12-23
Recruiting
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
NCT06610734Small Cell Lung Cancer Extensive Stage
Sichuan University
Phase 2
202
Sichuan
2024-12-23
Recruiting
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663Solid Tumor, Solid Carcinoma, Uroepithelial Carcinoma, Bladder Cancer
RenJi Hospital
Phase 2/3
400
Shanghai
2024-12-23
Recruiting
Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients
NCT06665113Parkinson Disease, Idiopathic
Kezhong Zhang
Not applicable
12
Nanjing
2024-12-23
Recruiting
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
NCT07251309Hyperkalemia
Waterstone Pharmaceutical (Wuhan) Co., LTD.
Phase 3
420
Bengbu, Wuhu, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhanjiang, Huizhou
2024-12-23
Recruiting
Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT06735144Malignant Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
200
Guangzhou
2024-12-23
Recruiting
Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis
NCT06939582Radiation-induced Oral Mucositis
Xingchen Peng
Phase 1/2
158
Chengdu
2024-12-22
Recruiting
Efficacy and Safety of Colorectal Anastomotic Leak Testing
NCT06865638Colorectal Cancer, Leakage Testing, Colorectal Surgery, Complications
Nanchong Central Hospital
Not applicable
264
Nanchong
2024-12-22
Recruiting
D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC
NCT07016126NSCLC (Non-small Cell Lung Cancer)
Guangdong Provincial People's Hospital
Phase 3
70
Guangzhou
2024-12-22
Active, closed
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
NCT06679985Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2
72
2024-12-20
Recruiting
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
NCT06424301Retinoblastoma, Refractory
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
2
Shanghai
2024-12-20
Recruiting
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
NCT06643000Non-small Cell Lung Cancer, Leptomeningeal Metastasis, EGFR Gene Mutation
Henan Cancer Hospital
Not applicable
60
Zhengzhou
2024-12-20
Recruiting
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
NCT06780410Primary Hyperlipidemia
Gan & Lee Pharmaceuticals.
Phase 3
240
Beijing
2024-12-20
Not yet open
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
NCT06745973Chronic Hepatitis B
Epigenic Therapeutics, Inc
Phase EARLY_PHASE1
20
Shanghai
2024-12-20
Not yet open
Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer
NCT06750848Advanced Breast Cancer
Jundong Wu
Phase 2
48
Shantou
2024-12-20
Recruiting
Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma
NCT06704555Follicular Lymphoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2
20
Tianjin
2024-12-20
Not yet open
Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
NCT06739278Crohn Disease
Second Affiliated Hospital of Wenzhou Medical University
Observational
119
Wenzhou
2024-12-20
Recruiting
The Optimal Radioimmunotherapy Combinations for Advanced TNBC
NCT06735131Triple-Negative Breast Cancer (TNBC)
Sun Yat-sen University
Phase 2
60
Guangzhou
2024-12-20
Active, closed
A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma
NCT06680947Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
225
Shanghai
2024-12-20
Recruiting
Removable Titanium Clip Treatment for Acute Variceal Hemorrhage from the Gastric Fundus
NCT06736314Gastric Variceal Bleeding
Shupei Li
Not applicable
10
Nanjing
2024-12-20
Not yet open
Study of Acupuncture to Control Weight and Improve Pregnancy Rates in Overweight/Obese PCOS Patients
NCT06717087Polycystic Ovary Syndrome, Metformin, Acupuncture
RenJi Hospital
Not applicable
92
Shanghai
2024-12-20
Active, closed
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
NCT06806046Solid Tumors, Colorectal Cancer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 1
12
Beijing, Guangzhou, Hangzhou
2024-12-20
Recruiting
A Study of GC101 TIL in Advanced Melanoma
NCT06703398Melanoma
Shanghai Juncell Therapeutics
Phase 2
98
Beijing
2024-12-20
Active, closed
Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer
NCT07130643HR+/HER2- Breast Cancer
Xinhong Wu, PhD
Phase 2
40
Wuhan
2024-12-20
Recruiting
Theory-based Health Behaviour Change Intervention in Individuals of Metabolic Syndrome With Chronic Kidney Disease
NCT06715735Chronic Kidney Diseases, Metabolic Syndrome
Chinese University of Hong Kong
Not applicable
160
Chengdu
2024-12-20
Recruiting
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
NCT06715007Stroke, Ischemic, Small Vessel Cerebrovascular Disease, White Matter Hyperintensity
The First Affiliated Hospital with Nanjing Medical University
Observational
300
Nanjing
2024-12-20
Recruiting
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
NCT06755190Ocular Diseases
The Eye Hospital of Wenzhou Medical University
Observational
5,000,000
Zhuhai, Wenzhou
2024-12-20
Recruiting
Clinical and Metabolomics Studies on the Improvement of Ovarian Reserve by Acupoint Photodynamic Therapy and Traditional Chinese Medicine Treatment
NCT07376824Diminished Ovarian Reserve (DOR)
Peking Union Medical College Hospital
Phase 3
90
Beijing
2024-12-20
Not yet open
TAES Alleviate Post-VATS Depression
NCT06718231Depression After Video-assisted Thoracoscopic Surgery
Fuling Central Hospital of Chongqing City
Not applicable
120
Fuling
2024-12-20
Not yet open
Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis
NCT06741800Rhinitis, Allergic
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-12-20
Recruiting
Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
NCT06754085Prostate Cancer
HTA Co., Ltd.
Phase 3
131
Guangzhou
2024-12-19
Active, closed
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
NCT06604715Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Phase 1
17
2024-12-19
Recruiting
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334Prostate Cancer, PET/CT
Anhui Provincial Hospital
Phase EARLY_PHASE1
30
Hefei
2024-12-19
Active, closed
Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.
NCT06722664Gastric Mucosal Lesion
Healthgen Biotechnology Corp.
Phase 2
336
Beijing, Wuhan, Hohhot
2024-12-19
Recruiting
Exploring the Feasibility of Silk Fibroin Surgical Mesh in Rotator Cuff Tears Repair Enhancement
NCT06766630Rotator Cuff Tear
Weiliang Shen, Ph.D., M.D.
Phase 2/3
20
Hangzhou
2024-12-19
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
NCT06736574Heart Failure, Heart Failure With Reduced Ejection Fraction
Cytokinetics
Phase 3
1,800
Beijing, Lanzhou, Guangzhou, Shenzhen, Nanning, Luoyang, Changsha, Chifeng
2024-12-19
Recruiting
Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
NCT06757153Glioblastoma (GBM)
Zhongnan Hospital
Phase EARLY_PHASE1
15
Wuhan
2024-12-19
Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
NCT06500702Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
Sanofi
Phase 2
84
Beijing, Chengdu, Shanghai
2024-12-19
Recruiting
Spatially Fractionated Radiotherapy for Tumor Treatment
NCT07774819Radiotherapy-Induced Immune Priming
Xu Zhi-yuan
Phase 1/2
126
Shenzhen
2024-12-19
Recruiting
Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07007910m CRPC
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
90
Chengdu
2024-12-18
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
NCT06656494Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
266
Hefei, Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Nanchang
2024-12-18
Active, closed
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
NCT06742190Multifocal Motor Neuropathy (MMN), MMN
argenx
Phase 3
154
Shanghai
2024-12-18
Recruiting
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
NCT06687070Platinum-resistant Recurrent Ovarian Cancer, Advanced Solid Tumor
Ascentage Pharma Group Inc.
Phase 1
90
Guangzhou
2024-12-17
Recruiting
Risk Factors for Complications After Cranioplasty
NCT06740773Cranioplasty, Postoperative Complications, Risk Assessment
Qilu Hospital of Shandong University
Observational
1,000
Chongqing, Xi'an, Jinan
2024-12-17
Recruiting
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
NCT06726460Electrolyte Disorder, Arrhythmia, Stroke
Zhujiang Hospital
Observational
200
Guangzhou
2024-12-17
Active, closed
A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer (TAISHAN-302)
NCT06612151Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
438
Guangzhou
2024-12-17
Recruiting
Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis
NCT06742008Viral Myocarditis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
300
Wuhan
2024-12-17
Recruiting
A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors
NCT06725381Solid Malignancies
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
138
Guangzhou, Nanning, Wuhan, Changsha, Nanjing, Jinan, Linyi, Chengdu
2024-12-17
Recruiting
Evaluating the Prognostic Impact of Anti-ฮฒ1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy
NCT06741995Dilated Cardiomyopathy (DCM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Wuhan
2024-12-17
Recruiting
Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer
NCT06702891Gastric Cardia Cancer
Qilu Hospital of Shandong University
Observational
20
Jinan
2024-12-17
Recruiting
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
NCT06793332Triple-Negative Breast Cancer (TNBC), Brain Metastases
Fudan University
Phase 2
39
Shanghai
2024-12-17
Not yet open
Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT06752408Non Small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2
316
Beijing
2024-12-17
Recruiting
Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors
NCT06727812Solid Tumors
Shandong Suncadia Medicine Co., Ltd.
Phase 1
206
Nanjing, Chengdu
2024-12-17
Recruiting
High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia
NCT06959147Herpes Zoster Pain, Neuralgia, Postherpetic
Shirong Tan
Phase 4
46
Zunyi
2024-12-17
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101Multiple Myeloma, Newly Diagnosed Multiple Myeloma
GlaxoSmithKline
Phase 3
520
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai
2024-12-16
Recruiting
A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion
NCT06559475Acute Ischemic Stroke, Endovascular Thrombectomy
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
360
Hefei
2024-12-16
Recruiting
Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures
NCT06203782Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
102
Hangzhou
2024-12-16
Rows per page Showing 10201–10300 of 19052
Previous 101 102 103 104 105 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=103

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.